Scripps Research Logo

The Burton Laboratory

LATEST NEWS


Scripps Research Institute Wins $77 Million to Develop AIDS Vaccine Center


Team Finds New Point of Attach on HIV for Vaccine Development

Promising HIV Target Found

Hitting a Moving Target: AIDS Vaccine Could Work Against Changeable Site on HIV

Sok D, van Gils MJ, Pauthner M, Julien JP, Saye-Francisco KL, Hsueh J, Briney B, Lee JH, Le KM, Lee PS, Hua Y, Seaman MS, Moore JP, Ward AB, Wilson IA, Sanders RW, Burton DR. 2014. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex. Proc Natl Acad Sci U S A. 111:17624-17629.

Doores KJ, Kong L, Krumm SA, Le KM, Sok D, Laserson U, Garces F, Poignard P, Wilson IA, Burton DR. 2014.Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV Envelope. J Virol. 89:1105-1118.

Garces F, Sok D, Kong L, McBride R, Kim HJ, Saye-Francisco KF, Julien JP, Hua Y, Cupo A, Moore JP, Paulson JC, Ward AB, Burton DR, Wilson IA. 2014. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell. 159:69-79.

trimer
CHAVI-ID